TTBD

Oregon Science Startup Forum, April 22

Registration is now open for the Oregon Science Startup Forum, a one-day course in science entrepreneurship, hosted by the Portland Section of the American Chemical Society. Hear the startup experiences of science entrepreneurs from around Oregon Learn from investors, intellectual property lawyers and experts in turning science into businesses Equip yourself with specific steps to start a successful science business Saturday, April 22 9 a.m. to 5 p.m.  Networking Reception 5 p.m. to 7 p.m.  … Read More

Technology Transfer and Business Development—satisfaction survey open until March 31

You’re invited to give your feedback on OHSU’s Technology Transfer and Business Development. The team serves as a resource for innovative and entrepreneurial thinking at OHSU, supporting the university through intellectual property protection, the formation of startup companies, facilitating industry collaborations, and promoting strategic partnerships. Technology Transfer and Business Development  satisfaction survey.  Complete the survey by March 31 at 3 p.m. Technology Transfer and Business Development’s goal is to ensure that OHSU innovations are developed into … Read More

TTBD Innovator Spotlight: Bill Rooney, Ph.D.

In the coming year, patent-pending imaging software developed by OHSU scientists will be used to validate, for the first time in humans, a new imaging approach to map brain metabolism at high spatial resolution and determine if metabolic deficits are common in individuals with progressive multiple sclerosis. Part of what makes translation of this study to the human brain possible is the new software, which was developed by a team led by Bill Rooney, Ph.D., professor … Read More

Vaccine technology developed by OHSU researchers acquired by industry

OHSU researchers made international headlines in 2013 when they published findings that their HIV vaccine not only controlled SIV, the nonhuman primate form of HIV, but cleared it in nearly 60 percent of the monkeys in the trial. The HIV vaccine—developed by of a team of scientists at the OHSU Vaccine and Gene Therapy Institute that includes Jay Nelson, Ph.D.; Klaus Frueh, Ph.D.; Scott Hansen, Ph.D.; and Louis J. Picker, M.D.—has shown such promise in … Read More

AstraZeneca open innovation seminar, Jan. 26

Academic researchers interested in partnering with industry are invited to an informational seminar hosted by OHSU Technology Transfer and Business Development with members from AstraZeneca. Information will be presented on AstraZeneca’s Open Innovation Program and future collaboration opportunities with OHSU. OHSU researchers involved in the Open Innovation Program will enjoy access to resources ranging from optimized compounds and compound libraries to specialized technologies and know-how. Thursday, Jan. 26 3–4 p.m. Mackenzie Hall 3198 All are welcome to … Read More

2017 ICOregon Innovation Showcase registration open

OHSU builds collaborations and resources that help investigators translate research innovations into medical products and services. This is one of the ways we improve human health and wellness. Faculty, students, and the public are invited to attend the 2017 ICOregon Innovation Showcase to learn more about available resources that help make this translation happen. The event will bring together Oregon’s four major research universities, industry, and government to demonstrate how our universities are a driving force in the Oregon … Read More

Biomedical Innovation Program – moving innovations to market

For research scientists whose technical innovations have the potential to improve patient care, OHSU created the Biomedical Innovation Program. For four years now, BIP has been providing expertise and resources to steward innovations from the laboratory to clinical application through the process of commercialization. The program is a joint effort between Technology Transfer and Business Development and the Oregon Clinical and Translational Research Institute. To mark this occasion, the Oregon Clinical and Translational Research Institute sat down … Read More

OHSU innovators: Get support to commercialize your idea, Nov. 9

Technology Transfer and Business Development invites all OHSU innovators – faculty, students, fellows, employees – to a lunchtime gathering to learn about its expanded entrepreneur-in-residence program. Veterans Dick Rylander and Bob Masterson will be joined by two new entrepreneurs-in-residence Rob Arnold and Steve Runnels, who will share who will share details on how their expertise in starting health care and life science companies can help OHSU innovators commercialize their technologies. They will talk about how they … Read More

Jan. 1: New F&A rates for non-clinical, industry-sponsored research

OHSU’s Facilities and Administrative rate for industry-sponsored research agreements will increase by 3%, effective January 1, 2017. The new rate will not apply to industry-sponsored clinical trials, federal awards such as SBIR/STTR awards, or ONPRC industry-sponsored agreements, but it will apply to all other industry-sponsored agreements entered into by Technology Transfer and Business Development on or after January 1, 2017. All currently funded projects will remain fixed at their awarded rate unless additional funding is … Read More

Technology Transfer and Business Development awards

Four OHSU researchers were honored at OHSU Technology Transfer and Business Development’s 11th award ceremony on Wednesday, Oct. 12. The event is held each year to honor members of the OHSU research community, recognize new companies based on OHSU technology, and celebrate TTBD’s numerous milestones and accomplishments. Sudarshan Anand, Ph.D., assistant professor of cell and developmental biology, was recognized as New Inventor of the Year for his work with TTBD Understanding the role of microRNAs in cancer blood vessels … Read More

Welcome to the Research News Blog

Welcome to the Research News Blog

OHSU Research News is your portal to information about all things research at Oregon Health & Science University. Visit often for updates on events, discoveries, and important funding information.

Participation Guidelines

Remember: information you share here is public; it isn't medical advice. Need advice or treatment? Contact your healthcare provider directly. Read our Terms of Use and this disclaimer for details.

Categories

Archives